Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
West Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
31 July
BriaCell Therapeutics Corp. has filed 323 SEC EDGAR filings since 20 Jun 2014

SEC filing history

Showing 176-200 of 323 matching filings.

Per page
25
Current page
8
3

3 filing

Filing date
02 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92289

SC 13G

Filing date
01 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
18 Jul 2022
Reporting date
18 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
05 Jul 2022
Reporting date
05 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
29 Jun 2022
Reporting date
29 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
24 Jun 2022
Reporting date
24 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
18 May 2022
Reporting date
18 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92289

SC 13G filing

Filing date
25 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
13 Apr 2022
Reporting date
13 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
12 Apr 2022
Reporting date
12 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
07 Apr 2022
Reporting date
07 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-257104

424B3 filing

Filing date
21 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-257104

EFFECT filing

Filing date
16 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-257104

POS AM filing

Filing date
10 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .